GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Price-to-Free-Cash-Flow

Bruker (Bruker) Price-to-Free-Cash-Flow

: 47.07 (As of Today)
View and export this data going back to 2000. Start your Free Trial

As of today (2024-04-23), Bruker's share price is $78.05. Bruker's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.66. Hence, Bruker's Price-to-Free-Cash-Flow Ratio for today is 47.07.

The historical rank and industry rank for Bruker's Price-to-Free-Cash-Flow or its related term are showing as below:

BRKR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 18.95   Med: 41.85   Max: 92.14
Current: 47.08

During the past 13 years, Bruker's highest Price-to-Free-Cash-Flow Ratio was 92.14. The lowest was 18.95. And the median was 41.85.

BRKR's Price-to-Free-Cash-Flow is ranked worse than
69.55% of 335 companies
in the Medical Devices & Instruments industry
Industry Median: 31.24 vs BRKR: 47.08

Bruker's Free Cash Flow per Share for the three months ended in Dec. 2023 was $1.19. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.66.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Bruker was 70.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 2.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 4.70% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 10.20% per year.

During the past 13 years, Bruker's highest 3-Year average Free Cash Flow per Share Growth Rate was 58.30% per year. The lowest was -24.30% per year. And the median was 2.75% per year.


Bruker Price-to-Free-Cash-Flow Historical Data

The historical data trend for Bruker's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.82 35.61 67.40 70.32 44.48

Bruker Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.32 77.91 54.47 44.66 44.48

Competitive Comparison

For the Medical Devices subindustry, Bruker's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker Price-to-Free-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bruker's Price-to-Free-Cash-Flow falls into.



Bruker Price-to-Free-Cash-Flow Calculation

Bruker's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=78.05/1.658
=47.07

Bruker's Share Price of today is $78.05.
Bruker's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.66.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Bruker  (NAS:BRKR) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Bruker Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bruker's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker (Bruker) Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.
Executives
Frank H Laukien director, 10 percent owner, officer: CEO, President C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Richard A Packer director 9 KENDALL DRIVE, WESTBOROUGH MA 01581
Philip Ma director C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch officer: Pres. Bruker Nano Inc. BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega officer: Group President Bruker CALID BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause officer: Pres. & CEO, Bruker EST BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson director 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean director BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse officer: President, BioSpin Group 40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman officer: Vice President, Corp Contr. 55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Richard Kniss director 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Adelene Q Perkins director C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139